Culmerciclib trials for Breast cancer

All Culmerciclib trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Culmerciclib for Breast cancer

• A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.
  NCT07666555 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Culmerciclib in HR+/HER2+ Advanced Breast Cancer
  NCT07732491 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer
  NCT07616453 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location

Common questions

How many trials study Culmerciclib for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.